Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1959 2
1960 6
1961 11
1962 14
1963 8
1964 10
1965 8
1966 7
1967 11
1968 14
1969 3
1970 6
1971 9
1972 12
1973 8
1974 15
1975 13
1976 11
1977 11
1978 10
1979 7
1980 5
1981 9
1982 4
1983 8
1984 7
1985 2
1986 8
1987 8
1988 8
1989 1
1991 4
1992 3
1993 5
1995 4
1996 6
1997 4
1998 8
1999 5
2000 6
2001 6
2002 3
2003 5
2004 6
2005 8
2006 3
2008 2
2009 6
2010 4
2011 7
2012 5
2013 10
2014 7
2015 6
2016 3
2017 5
2018 6
2019 3
2021 2
2022 7
2024 2
2025 8
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

408 results

Results by year

Filters applied: . Clear all
Page 1
AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity.
Grunvald E, Shah R, Hernaez R, Chandar AK, Pickett-Blakely O, Teigen LM, Harindhanavudhi T, Sultan S, Singh S, Davitkov P; AGA Clinical Guidelines Committee. Grunvald E, et al. Gastroenterology. 2022 Nov;163(5):1198-1225. doi: 10.1053/j.gastro.2022.08.045. Epub 2022 Oct 20. Gastroenterology. 2022. PMID: 36273831
METHODS: A multidisciplinary panel of content experts and guideline methodologists used the Grading of Recommendations Assessment, Development and Evaluation framework to prioritize clinical questions, identify patient-centered outcomes, and conduct an evidence synthesis of the f …
METHODS: A multidisciplinary panel of content experts and guideline methodologists used the Grading of Recommendations Assessment, Developme …
Diethylpropion.
[No authors listed] [No authors listed] 2018 Jan 3. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2018 Jan 3. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644094 Free Books & Documents. Review.
Diethylpropion is a sympathomimetic amine and anorectic agent used for the short-term therapy of obesity. Diethylpropion has not been linked to either serum enzyme elevations or to clinically apparent acute liver injury....
Diethylpropion is a sympathomimetic amine and anorectic agent used for the short-term therapy of obesity. Diethylpropion has n …
Weight Loss Agents.
Hoofnagle JH. Hoofnagle JH. 2025 Jul 1. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2025 Jul 1. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644235 Free Books & Documents. Review.
Drugs for weight loss can be separated into those that suppress appetite (such as diethylpropion and phentermine) and those that block absorption of calories (orlistat). The anorexic agents that have been used for weight loss include sympathomimetic agents (such as diet …
Drugs for weight loss can be separated into those that suppress appetite (such as diethylpropion and phentermine) and those that bloc …
Pharmacotherapy for obesity.
Joo JK, Lee KS. Joo JK, et al. J Menopausal Med. 2014 Dec;20(3):90-6. doi: 10.6118/jmm.2014.20.3.90. Epub 2014 Dec 24. J Menopausal Med. 2014. PMID: 25580419 Free PMC article. Review.
Several sympathomimetic drugs such as benzphetamine, diethylpropion, phendimetrazine and phentermine, are approved for short term treatment due to their safety issues. ...
Several sympathomimetic drugs such as benzphetamine, diethylpropion, phendimetrazine and phentermine, are approved for short term tre …
Obesity.
Arterburn D, DeLaet D, Flum D. Arterburn D, et al. Clin Evid. 2005 Jun;(13):707-25. Clin Evid. 2005. PMID: 16135277 Review. No abstract available.
Pharmacotherapy for obesity.
Ioannides-Demos LL, Proietto J, McNeil JJ. Ioannides-Demos LL, et al. Drugs. 2005;65(10):1391-418. doi: 10.2165/00003495-200565100-00006. Drugs. 2005. PMID: 15977970 Review.
Pharmacotherapy for the management of obesity is primarily aimed at weight loss, weight loss maintenance and risk reduction, and has included thyroid hormone, amphetamines, phentermine, amfepramone (diethylpropion), phenylpropanolamine, mazindol, fenfluramines and, more re …
Pharmacotherapy for the management of obesity is primarily aimed at weight loss, weight loss maintenance and risk reduction, and has include …
Obesity in adults.
Delaet D, Schauer D. Delaet D, et al. BMJ Clin Evid. 2011 Mar 17;2011:0604. BMJ Clin Evid. 2011. PMID: 21411021 Free PMC article.
CONCLUSIONS: In this systematic review, we present information relating to the effectiveness and safety of the following interventions: bariatric surgery versus medical interventions, biliopancreatic diversion, diethylpropion, gastric bypass, gastric banding, mazindol, orl …
CONCLUSIONS: In this systematic review, we present information relating to the effectiveness and safety of the following interventions: bari …
Phentermine and anaesthesia.
Stephens LC, Katz SG. Stephens LC, et al. Anaesth Intensive Care. 2005 Aug;33(4):525-7. doi: 10.1177/0310057X0503300418. Anaesth Intensive Care. 2005. PMID: 16119498
The currently available anti-obesity medications are discussed: phentermine, diethylpropion, and sibutramine; all of which are sympathomimetics possessing noradrenaline and serotonin reuptake inhibitor activity. ...
The currently available anti-obesity medications are discussed: phentermine, diethylpropion, and sibutramine; all of which are sympat …
Drug-induced scleroderma.
Bourgeois P, Aeschlimann A. Bourgeois P, et al. Baillieres Clin Rheumatol. 1991 Apr;5(1):13-20. doi: 10.1016/s0950-3579(05)80293-6. Baillieres Clin Rheumatol. 1991. PMID: 1712674 Review. No abstract available.
Obesity.
Arterburn D. Arterburn D. Clin Evid. 2003 Dec;(10):676-89. Clin Evid. 2003. Update in: Clin Evid. 2004 Jun;(11):762-76. PMID: 15555115 Updated. Review. No abstract available.
408 results